Keith R Latham
CEO Chief Scientist at ITL Pharma, CTO at LIAS
- Role
- CEO & Chief Scientist at Itl Pharma
- Location
- Knoxville, TN, US
- LinkedIn followers
- 500 followers
About Keith R Latham
Since leaving the University system in 1989, Dr. Latham has served as Scientific Director and President of 6 additional companies, spawning multiple inventions and many commercialized products in the areas of artificial intelligence, statistical logic devices, eutectic gasses, media for culturing human stem cells, radio-protective compounds, targeted enzyme substrates, anti-viral vaccines and new chemistries for the synthesis of key synthetic intermediates and active pharmaceutical ingredients. Patents for methods of Controlled Drug Release and new drugs for the treatment of Hypothyroidism, Breast Cancer, Alzheimer\'s disease and Parkinson\'s disease have resulted.
Experience
CEO & Chief Scientist
Jan 1998 — Present
Inventor and Developer of over 28 drugs.
Education
University of California, San Francisco
Post Doctoral, Molecular Endocrinology & Pharmaceutical Chemistry
1974 — 1977
University of Southern California
Doctor of Philosophy (Ph.D.), Neurobiology of Aging
1968 — 1974
California State University, Long Beach
Bachelor's Degree, Biophysics
1965 — 1968
Skills
- Technology Transfer
- Pharmaceutical Research
- Medicinal Chemistry
- Hplc
- R&D
- Leadership
- High-Performance Liquid Chromatography (Hplc)
- Drug Development
- Pharmacology
- Biotechnology
- Research and Development (R&D)
- Analytical Chemistry
- Lifesciences
- Clinical Development
- Strategic Partnerships
- Clinical Trials
- Drug Discovery
- Pharmaceutical Industry
- Life Sciences
- Vaccines
- Medical Devices
- Clinical Research
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.